Rapid intracellular release of calcium in human platelets by stimulation of 5‐HT2‐receptors

P. Erne,A. Pletscher
DOI: https://doi.org/10.1111/j.1476-5381.1985.tb12939.x
IF: 7.3
1985-02-01
British Journal of Pharmacology
Abstract:1 The concentration of intracellular free Ca2+ ([Ca2+]i) in human blood platelets was measured by use of the fluorescent probe quin‐2. 2 5‐Hydroxytryptamine (5‐HT) caused a rapid increase of [Ca2+]i in the presence or absence of Ca2+ in the medium. The [Ca2+]i‐rise was less marked in the absence of Ca2+ and could be antagonized by 8‐(N,N‐diethylamino)octyl‐3,4,5‐trimethoxybenzoate‐hydrochloride (TMB‐8), an inhibitor of calcium release from internal stores. 3 5‐HT induced a shape change reaction in the presence or absence of extracellular Ca2+, but the pEC50 of 5‐HT was slightly higher in the presence of the cation. Shape change reaction and [Ca2+]i‐rise showed similar time courses. 4 Various 5‐HT‐agonists caused a rise of [Ca2+]i, whereas 5‐HT‐antagonists, but not the 5‐HT‐uptake inhibitor desmethylimipramine and the α2‐adrenoceptor antagonist yohimbine, counteracted the 5‐HT‐induced rise of the cation in a stereospecific manner. The antagonists were more potent than the agonists. The orders of potencies of the drugs affecting [Ca2+]i and platelet shape were similar. 5 It is concluded that stimulation of 5‐HT2‐receptors of platelets causes a rapid release of intracellular calcium which, by activation of the contractile system, mediates the shape change reaction.
What problem does this paper attempt to address?